“Everyone who cares about the future of U.S. domestic policy should pay attention to this effort in California to build a public option for prescription drug manufacturing,” said one expert. “Potentially game-changing.”

By Kenny Stancil  Published 6-8-2022 by Common Dreams

Photo: Brian J. Matis/flickr/CC

With insulin prices in the United States so astronomical that experts have accused the federal government and pharmaceutical industry of violating human rights, California is exploring a plan to produce its own generic version of the lifesaving medicine and make it accessible to millions of people with diabetes.

“Everyone who cares about the future of U.S. domestic policy should pay attention to this effort in California to build a public option for prescription drug manufacturing,” Steph Sterling, vice president of the Roosevelt Institute, a progressive think tank, said Tuesday. Continue reading →